DS
PLXP

David Shaw’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

David Shaw’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-64,556
Closed -$157K – 5698
2022
Q2 		$157K Sell
64,556
-47,069
-42% -$131K ﹤0.01% 4621
2022
Q1 		$451K Buy
+111,625
New +$612K ﹤0.01% 4434

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SGCA
Steel Grove Capital Advisors Memphis, Tennessee $1.07B AUM 26.35% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return

David Shaw's PLXP Position: Q3 2022 in Review

David Shaw sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2022, closing a stake of 64,556 shares — an estimated $157K sold.

David Shaw first reported a position in PLXP in Q1 2022 and held it in 2 quarters. The position peaked at $451K in Q1 2022. 40 funds tracked by Wall St. Rank hold PLXP as of Q3 2022.

  • David Shaw reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • David Shaw sold 64,556 PLx Pharma Inc. Common Stock shares in Q3 2022, an estimated $157K.
  • David Shaw first reported a position in PLx Pharma Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • David Shaw's PLx Pharma Inc. Common Stock position peaked at $451K in Q1 2022.
  • 40 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.